Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Advanced lung cancer patients' group | Other | Evaluation of the demographic, clinical, histological and molecular characteristics of advanced lung cancer at the time of Diagnosis |
| Measure | Description | Time Frame |
|---|---|---|
| Distribution of histologic subtypes | The investigators will assess the prevalence of histologic subtypes in patients with advanced lung cancer | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Distribution of histologic subtypes according to clinical and radiological characteristics | The investigators will assess the prevalence of different histologic subtypes according to clinical and imaging characteristics | 24 months |
| Molecular profiling |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Consecutive, treatment-naïve, patients with clinical and radiological suspicion of advanced lung cancer referred for the initial diagnosis/staging/molecular profiling.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Rocco Trisolini, MD | Contact | 0630154163 | rocco.trisolini@policlinicogemelli.it |
| Name | Affiliation | Role |
|---|---|---|
| Rocco Trisolini | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS | Recruiting | Roma | Italy |
The investigators will decide how to share the data at the end of the study upon reasonable request to be addressed to the principal investigator.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Prevalence of individual molecular markers in patients with advanced non-squamous non-small cell lung cancer histology |
| 24 months |
| Time to diagnosis | Time lag between onset of symptoms (if any) and invasive testing | 24 months |
| Istituto Nazionale Tumori Regina Elena | Not yet recruiting | Roma | Italy |
|
| Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not yet recruiting | Roma | Italy |
|
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |